SIONNA THERAPEUTICS

sionna-therapeutics-logo

Sionna Therapeutics is developing novel small molecule therapies to treat cystic fibrosis (CF).

#People #Financial #Website #More

SIONNA THERAPEUTICS

Social Links:

Industry:
Biotechnology Genetics Health Care Medical Pharmaceutical Therapeutics

Founded:
2018-01-01

Address:
Natick, Massachusetts, United States

Country:
United States

Website Url:
http://www.sionnatx.com

Total Employee:
11+

Status:
Active

Contact:
617-819-2020

Email Addresses:
[email protected]

Total Funding:
110 M USD



Current Advisors List

bruce-booth_image

Bruce Booth Board Member @ Sionna Therapeutics
Board_member
2022-04-19

joshua-resnick_image

Joshua Resnick Board Member @ Sionna Therapeutics
Board_member
2022-04-20

lucian-iancovici_image

Lucian Iancovici Board Member @ Sionna Therapeutics
Board_member
2022-04-19

adam-rosenberg_image

Adam Rosenberg Board Member @ Sionna Therapeutics
Board_member
2022-04-19

peter-thompson_image

Peter Thompson Board Member @ Sionna Therapeutics
Board_member
2022-04-19

Investors List

the-cystic-fibrosis-foundation_image

Cystic Fibrosis Foundation

Cystic Fibrosis Foundation investment in Series B - Sionna Therapeutics

tpg-rise_image

TPG Rise Climate Fund

TPG Rise Climate Fund investment in Series B - Sionna Therapeutics

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - Sionna Therapeutics

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series B - Sionna Therapeutics

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Series B - Sionna Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series B - Sionna Therapeutics

Official Site Inspections

http://www.sionnatx.com

  • Host name: 248.236.154.104.bc.googleusercontent.com
  • IP address: 104.154.236.248
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Sionna Therapeutics"

About Us - Sionna Therapeutics

For three decades since the discovery of the genetic defects that cause cystic fibrosis (CF), researchers have made remarkable advances for patients. Yet the ultimate goal of CF drug …See details»

Sionna Therapeutics - Crunchbase Company Profile

Contact Email [email protected] Phone Number 617-819-2020 Sionna Therapeutics was formed in late 2019, leveraging 10 years of large pharma scientific investment and expertise.See details»

Sionna Therapeutics Company Profile | Management and

Www.sionnatx.com Sionna Therapeutics Profile and History Sionna Therapeutics is a clinical-stage life sciences company dedicated to developing highly effective and differentiated …See details»

Sionna Therapeutics - LinkedIn

Sionna Therapeutics | 4,455 followers on LinkedIn. Dedicated to delivering therapies that could be transformational for people living with cystic fibrosis. | We are a life sciences company that is ...See details»

Sionna Company Profile 2024: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Sionna. Use the PitchBook Platform to explore the full profile.See details»

Sionna Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

2 days ago www.sionnatx.com. Startups | Holding Company | 2018 | Massachusetts, United States | 10-50 | www.sionnatx.com. Last update 31 Dec 2024. Overview. Pipeline. Deal. …See details»

Associate Director, Human Resources - Sionna Therapeutics

We are accepting resumes for the position at [email protected]. Key Responsibilities: HR Compliance and Legal Adherence. Ensure compliance with federal and state HR regulations, …See details»

Sionna - Company Profile - Tracxn

Nov 7, 2024 What are the most recent funding rounds of Sionna? Its latest funding round was a Series C round on Mar 06, 2024 for $182M. 3 investors participated in its latest round, lead by …See details»

Sionna Therapeutics: Contact Details and Business Profile

How many people are employed at Sionna Therapeutics? 32 people are employed at Sionna Therapeutics.See details»

Sionna Therapeutics Company Profile -Sales, Contacts, …

This organization primarily operates in the Internal Medicine Practitioners business / industry within the Health Services sector. This organization has been operating for approximately 5 …See details»

Org Chart Sionna Therapeutics - The Official Board

For each of our 1,263,725 listed executives, discover their exact roles and their biographies.See details»

Series B - Sionna Therapeutics - 2022-04-19 - Crunchbase

Apr 19, 2022 Organization Name . Sionna Therapeutics . Announced Date Apr 19, 2022; Funding Type Series B; Funding Stage Early Stage Venture; Money Raised . $110M. ...See details»

Sionna Therapeutics Announces Appointment of Jennifer …

Jun 3, 2024 Ms. Fitzpatrick most recently served as Vice President, Corporate Counsel at Sage Therapeutics, where she built and led a team providing legal counsel and contracting support …See details»

Sionna Therapeutics Announces $182 Million Series C Financing to ...

Sionna Therapeutics, a clinical-stage life sciences company dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF), today announced the closing of …See details»

Sionna Therapeutics - Overview, News & Similar companies

Sionna Therapeutics contact info: Phone number: (617) 819-2020 Website: www.sionnatx.com What does Sionna Therapeutics do? Sionna Therapeutics is a clinical-stage life sciences …See details»

Senior Manager/Associate Director, Accounting & Reporting

The Accounting & Reporting position is part of the growing finance and accounting team. This role will partner heavily with our Assistant Controller and key stakeholders across the organization …See details»

Sionna Therapeutics Staff Directory & Email Format - ContactOut

The widely used Sionna Therapeutics email format is {f}{last}@sionnatx.com (e.g. [email protected]), which is used 75.00% of the time. Sionna Therapeutics Email Formats Example …See details»

Science - Sionna Therapeutics

Nov 3, 2023 Cystic fibrosis (CF) is a serious, potentially fatal inherited disease resulting from mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which …See details»

Mike Cloonan, President & CEO nd Annual - Sionna Therapeutics

Mike Cloonan, President & CEO 42nd Annual J.P. Morgan Healthcare Conference January 2024See details»

linkstock.net © 2022. All rights reserved